Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1986 Jan 15;233(2):459–463. doi: 10.1042/bj2330459

Purification and characterization of ascamycin-hydrolysing aminopeptidase from Xanthomonas citri.

H Osada, K Isono
PMCID: PMC1153047  PMID: 3754135

Abstract

A nucleoside antibiotic, ascamycin (9-beta-[5'-0-(N-L-alanyl) sulphamoyl-D-ribofuranosyl]-2-chloroadenine), has a selective antibacterial activity against Xanthomonas species. When ascamycin was dealanylated, dealanylascamycin showed a broad antibacterial activity against various Gram-negative and Gram-positive bacteria. Xanthomonas citri is susceptible to ascamycin by virtue of the ascamycin-dealanylating enzyme on the cell surface [Osada & Isono (1985) Antimicrob. Agents Chemother. 27, 230-233]. The enzyme (Xc aminopeptidase) was purified from X. citri cells by successive DEAE-cellulose, chromatofocusing and Sephadex G-100 column chromatography to a homogeneous state. The purified enzyme exhibited a single band with an Mr of 38 000 in SDS/polyacrylamide-gel electrophoresis. Gel filtration on a calibrated column indicated a similar Mr value. The isoelectric point of the enzyme was 5.7. The enzyme catalysed the hydrolysis of the alanyl group of ascamycin and liberated alanine from the sulphamoyl nucleoside. The enzyme also catalysed the hydrolysis of L-proline beta-naphthylamide and L-alanine beta-naphthylamide. The optimal pH and temperature for enzyme activity were pH 7.5-8.0 and 35-40 degrees C respectively. The enzyme was inhibited by thiol-enzyme inhibitors (i.e. rho-chloromercuribenzoate and N-ethylmaleimide), but was not affected by various naturally occurring aminopeptidase inhibitors (i.e. amastatin, bestatin, pepstatin and leupeptin). Mn2+ and Mg2+ activated the enzyme, whereas Cu2+, Zn2+ and Cd2+ were inhibitory.

Full text

PDF
459

Images in this article

461Fig. 3.
on p.461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benveniste R., Davies J. R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. FEBS Lett. 1971 May 20;14(5):293–296. doi: 10.1016/0014-5793(71)80282-x. [DOI] [PubMed] [Google Scholar]
  3. Brzezinska M., Benveniste R., Davies J., Daniels P. J., Weinstein J. Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. Biochemistry. 1972 Feb 29;11(5):761–765. doi: 10.1021/bi00755a013. [DOI] [PubMed] [Google Scholar]
  4. Davies J., Smith D. I. Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol. 1978;32:469–518. doi: 10.1146/annurev.mi.32.100178.002345. [DOI] [PubMed] [Google Scholar]
  5. Dowding J. E. Mechanisms of gentamicin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1977 Jan;11(1):47–50. doi: 10.1128/aac.11.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Isono K., Uramoto M., Kusakabe H., Miyata N., Koyama T., Ubukata M., Sethi S. K., McCloskey J. A. Ascamycin and dealanylascamycin, nucleoside antibiotics from Streptomyces sp. J Antibiot (Tokyo) 1984 Jun;37(6):670–672. doi: 10.7164/antibiotics.37.670. [DOI] [PubMed] [Google Scholar]
  7. Khilji M. A., Bailey G. S. The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor. Biochim Biophys Acta. 1978 Nov 10;527(1):282–288. doi: 10.1016/0005-2744(78)90279-6. [DOI] [PubMed] [Google Scholar]
  8. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  9. Lee H. J., LaRue J. N., Wilson I. B. A simple spectrophotometric assay for amino acyl arylamidases (naphthylamidases, aminopeptidases). Anal Biochem. 1971 Jun;41(2):397–401. doi: 10.1016/0003-2697(71)90157-6. [DOI] [PubMed] [Google Scholar]
  10. Ninomiya K., Kawatani K., Tanaka S., Kawata S., Makisumi S. Purification and properties of a proline iminopeptidase from apricot seeds. J Biochem. 1982 Aug;92(2):413–421. doi: 10.1093/oxfordjournals.jbchem.a133948. [DOI] [PubMed] [Google Scholar]
  11. Nordwig A., Mayer H. The cleavage of prolyl peptides by kidney peptidases. Detection of a new peptidase capable of removing N-terminal proline. Hoppe Seylers Z Physiol Chem. 1973 Apr;354(4):380–383. doi: 10.1515/bchm2.1973.354.1.380. [DOI] [PubMed] [Google Scholar]
  12. Osada H., Isono K. Mechanism of action and selective toxicity of ascamycin, a nucleoside antibiotic. Antimicrob Agents Chemother. 1985 Feb;27(2):230–233. doi: 10.1128/aac.27.2.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Otsuji N., Horiuchi T., Nakata A., Kawamata J. Strains of Escherichia coli hypersensitive to representative carcinostatic and carcinogenic agents. J Antibiot (Tokyo) 1978 Aug;31(8):794–796. doi: 10.7164/antibiotics.31.794. [DOI] [PubMed] [Google Scholar]
  14. SARID S., BERGER A., KATCHALSKI E. Proline iminopeptidase. J Biol Chem. 1959 Jul;234(7):1740–1746. [PubMed] [Google Scholar]
  15. Sykes R. B., Matthew M. The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1976 Jun;2(2):115–157. doi: 10.1093/jac/2.2.115. [DOI] [PubMed] [Google Scholar]
  16. Yoshimoto T., Saeki T., Tsuru D. Proline iminopeptidase from Bacillus megaterium: purification and characterization. J Biochem. 1983 Feb;93(2):469–477. doi: 10.1093/oxfordjournals.jbchem.a134201. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES